Journal
SUBSTANCE USE & MISUSE
Volume 40, Issue 13-14, Pages 2021-2041Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/10826080500294924
Keywords
substance use; mood disorders; anxiety disorders; depression; bipolar disorder; panic disorder; post-traumatic stress disorder; obsessive compulsive disorder; social phobia; alcohol; cocaine; marijuana; opiates
Categories
Ask authors/readers for more resources
Mood and anxiety disorders commonly co-occur with substance use disorders. Exploration of the neurobiology of substance use disorders and mood and anxiety disorders have found that the neural circuitry in mood, anxiety, and substance use disorders is clearly overlapping. These discoveries have encouraged the exploration of a number of pharmacotherapeutic agents in the treatment of co-occurring mood, anxiety, and substance use disorders. In this article, recent data on the pharmacotherapeutic treatment of mood and anxiety disorders in individuals with substance use disorders are reviewed. Some of the barriers to the use of pharmacotherapy in individuals with substance use disorders are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available